Stay updated on Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial

Sign up to get notified when there's something new on the Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.2 instead of Revision: v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-24T21:45:17.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Removed the site-wide notice about a lapse in government funding and potential processing delays, including references to cc.nih.gov and opm.gov. This change does not affect core trial information or study details.
    Difference
    0.4%
    Check dated 2025-11-17T19:49:55.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    No significant changes detected between the old and new page; only minor formatting or layout differences observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:52:47.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and a link to official sources; - Updated software version from v3.1.0 to v3.2.0; - Removed the old version reference.
    Difference
    5%
    Check dated 2025-10-06T04:25:49.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Expanded topic coverage to include Sudden Infant Death Syndrome and related terms, with a new revision v3.1.0; previous revision v3.0.2 removed.
    Difference
    1%
    Check dated 2025-09-29T00:58:27.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.1 to v3.0.2 and removed the 'Back to Top' link; overall, a minor update with no changes to pricing, stock, or dates.
    Difference
    0.3%
    Check dated 2025-09-14T18:44:27.000Z thumbnail image

Stay in the know with updates to Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial page.